JP2022505663A5 - - Google Patents

Info

Publication number
JP2022505663A5
JP2022505663A5 JP2021522078A JP2021522078A JP2022505663A5 JP 2022505663 A5 JP2022505663 A5 JP 2022505663A5 JP 2021522078 A JP2021522078 A JP 2021522078A JP 2021522078 A JP2021522078 A JP 2021522078A JP 2022505663 A5 JP2022505663 A5 JP 2022505663A5
Authority
JP
Japan
Application number
JP2021522078A
Other languages
Japanese (ja)
Other versions
JPWO2020086745A5 (https=
JP2022505663A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057702 external-priority patent/WO2020086745A1/en
Publication of JP2022505663A publication Critical patent/JP2022505663A/ja
Publication of JP2022505663A5 publication Critical patent/JP2022505663A5/ja
Publication of JPWO2020086745A5 publication Critical patent/JPWO2020086745A5/ja
Pending legal-status Critical Current

Links

JP2021522078A 2018-10-23 2019-10-23 IgM-Fcベース及びIgA-Fcベースの多価結合分子 Pending JP2022505663A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862749429P 2018-10-23 2018-10-23
US62/749,429 2018-10-23
PCT/US2019/057702 WO2020086745A1 (en) 2018-10-23 2019-10-23 MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES

Publications (3)

Publication Number Publication Date
JP2022505663A JP2022505663A (ja) 2022-01-14
JP2022505663A5 true JP2022505663A5 (https=) 2022-10-28
JPWO2020086745A5 JPWO2020086745A5 (https=) 2022-10-28

Family

ID=70331240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522078A Pending JP2022505663A (ja) 2018-10-23 2019-10-23 IgM-Fcベース及びIgA-Fcベースの多価結合分子

Country Status (11)

Country Link
US (1) US20210380701A1 (https=)
EP (1) EP3870223A4 (https=)
JP (1) JP2022505663A (https=)
KR (1) KR20210083260A (https=)
CN (1) CN112839677A (https=)
AU (1) AU2019368289A1 (https=)
CA (1) CA3113268A1 (https=)
IL (1) IL281901A (https=)
MX (1) MX2021004660A (https=)
SG (1) SG11202103720XA (https=)
WO (1) WO2020086745A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017512208A (ja) 2014-02-10 2017-05-18 アイジーエム バイオサイエンス, インコーポレイテッド IgA多重特異性結合分子
IL292311A (en) 2014-04-03 2022-06-01 Igm Biosciences Inc J-chain qualified
PT3247728T (pt) 2015-01-20 2020-07-16 Igm Biosciences Inc Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas
KR102357312B1 (ko) 2015-03-04 2022-02-03 아이쥐엠 바이오사이언스 인코포레이티드 Cd20 결합 분자 및 그의 용도
WO2016154593A1 (en) 2015-03-25 2016-09-29 Igm Biosciences, Inc. Multi-valent hepatitis b virus antigen binding molecules and uses thereof
WO2016168758A1 (en) 2015-04-17 2016-10-20 Igm Biosciences, Inc. Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
EP3824903A1 (en) 2015-09-30 2021-05-26 IGM Biosciences Inc. Binding molecules with modified j-chain
EP3356401B1 (en) 2015-09-30 2020-06-24 IGM Biosciences, Inc. Binding molecules with modified j-chain
JP6979971B2 (ja) 2016-05-09 2021-12-15 アイジーエム バイオサイエンシズ インコーポレイテッド 抗pd−l1抗体
US11401337B2 (en) 2017-04-07 2022-08-02 Igm Biosciences, Inc. Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function
CN111787951B (zh) 2018-03-01 2025-06-17 Igm生物科学股份有限公司 影响IgM血清半衰期的IgM Fc和J链突变
MX2022001934A (es) 2019-08-15 2022-03-11 Igm Biosciences Inc Moleculas de union multimericas inmunoestimuladoras.
US20210284716A1 (en) 2020-03-11 2021-09-16 Immunitybio, Inc. ACE2-Fc Trap
US12285480B2 (en) 2020-03-11 2025-04-29 Nantcell, Inc. Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
US11857620B2 (en) 2020-03-11 2024-01-02 Immunitybio, Inc. Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
BR112022021392A2 (pt) * 2020-04-22 2022-12-06 Igm Biosciences Inc Moléculas de ligação multiméricas de agonista de pd-1
CN116813759B (zh) * 2022-03-21 2025-11-28 中国科学院微生物研究所 纳米抗体r14的构建体及其应用
WO2023196995A1 (en) * 2022-04-07 2023-10-12 Repertoire Immune Medicines, Inc. T cell receptor multimers and uses thereof
CA3248964A1 (en) * 2022-04-15 2025-07-10 Imbiologics Corp. Fusion protein platform with an improved half-life
WO2024073700A2 (en) * 2022-09-30 2024-04-04 Igm Biosciences, Inc. Methods of treating autoimmune disorders using multimeric anti-cd20/anti-cd3 antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975355A2 (en) * 1996-06-14 2000-02-02 Smithkline Beecham Corporation Hexameric fusion proteins and uses therefor
DK2604693T3 (en) * 2008-07-21 2016-05-30 Apogenix Gmbh Single-chain TNFSF molecules
JP6205363B2 (ja) * 2011-09-26 2017-09-27 ジェイエヌ バイオサイエンシーズ エルエルシー ハイブリッド定常領域
JP2017512208A (ja) * 2014-02-10 2017-05-18 アイジーエム バイオサイエンス, インコーポレイテッド IgA多重特異性結合分子
PT3247728T (pt) * 2015-01-20 2020-07-16 Igm Biosciences Inc Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas
KR102357312B1 (ko) * 2015-03-04 2022-02-03 아이쥐엠 바이오사이언스 인코포레이티드 Cd20 결합 분자 및 그의 용도
WO2016154593A1 (en) * 2015-03-25 2016-09-29 Igm Biosciences, Inc. Multi-valent hepatitis b virus antigen binding molecules and uses thereof
AU2017300647A1 (en) * 2016-07-20 2019-02-07 Igm Biosciences, Inc. Multimeric GITR binding molecules and uses thereof
JP2019530640A (ja) * 2016-07-20 2019-10-24 アイジーエム バイオサイエンシズ インコーポレイテッド 多量体ox40結合分子及びその使用
US11401337B2 (en) * 2017-04-07 2022-08-02 Igm Biosciences, Inc. Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function

Similar Documents

Publication Publication Date Title
JP2022505663A5 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021016821A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021017310A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR102019023359A2 (https=)
BR112021018193A2 (https=)
BR112021013854A2 (https=)